Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

By Cahill E.S.   O'Hagan D.T.   Illum L.   Barnard A.   Mills K.H.G.   Redhead K.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 455-462

Elsevier

Access to resources Recommend Favorite

A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin

By Berstad A.K.H.   Holst J.   Mogster B.   Haugen I.L.   Haneberg B.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1473-1478

Elsevier

Access to resources Recommend Favorite

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens

By van den Berg B.M.   David S.   Beekhuizen H.   Mooi F.R.   van Furth R.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1118-1128

Elsevier

Access to resources Recommend Favorite

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM 197 ) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

By McNeela E.A.   O'Connor D.   Jabbal-Gill I.   Illum L.   Davis S.S.   Pizza M.   Peppoloni S.   Rappuoli R.   Mills K.H.G.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1188-1198

Elsevier

Access to resources Recommend Favorite